Recombinant SARS-CoV-2 Omicron B.1.1.529 variant spike RBD protein, Biotinylated

Biotin-conjugated recombinant SARS-CoV-2 Omicron variant spike S1 subunit protein RBD with 15 mutant sites (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H) with C-terminal His-tag, derived from the transfected human HEK293 cells.
$340.00
In stock
-
+

Product Description

Specifications

Size 10 ug
Species SARS-CoV-2
Accession Number QHD43416
Gene Symbols S
Protein Name / Synonyms Spike protein, S Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD)
Expressed Region Arg319-Phe541. Omicron 15 mutant sites (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H)
Expression System HEK293 cells
Conjugation Biotin
Tag C-terminal his-tag. The primary amino groups (-NH2) at the N-terminus and the side chains of lysine (K) residues were biotin-conjugated using the standard chemical labeling method.
Purification His-tag affinity purification by immobilized metal ion affinity chromatography (IMAC)
Purity >90%
Purity Determined By SDS-PAGE under reducing conditions and visualized by Coomassie blue staining
Molecular Weight (kDa) Recombinant protein product has a calculated molecular mass of ∼25 kDa. Due to the abundant glycosylation, it migrates as approximately ∼30 kDa protein bands in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. After deglycosylation under native and denature conditions, the protein presented as one reduced ∼25 kDa band.
Format Liquid
Formulation Supplied as a 0.2 µm filtered solution in PBS (pH 7.4)
Concentration (lot specific) Lot specific (see the label on the vial), determined by BCA protein assay
Specificity SARS-CoV-2 Omicron Variant B.1.1.529
Endotoxin Level < 0.5 EU per µg of the protein as determined by the LAL method
Protein Type Recombinant Protein
Estimated Lead Time 2-3 business days
Shipping Type Blue ice
Storage -20°C
SDS-PAGE Image
SDS-PAGE image
Figure 1. Deglycosylation analysis of purified recombinant proteins. The same amount of purified proteins were untreated (Lane 2) or treated with protein deglycosylation enzymes under native (Lane 3) or reducing (Lane 4) conditions. Deglycosylation treatment resulted in a mobility shift of the protein to produce one reduced band at the expected size, thus indicating that the untreated recombinant protein (Lane 2) was glycosylated.
Lane 1: protein standard ladder (kDa).
Lane 2: untreated protein.
Lane 3: treated protein with deglycosylation enzymes under native conditions.
Lane 4: treated protein with deglycosylation enzymes under denature conditions.

Stability & Storage

Shipping
Ice packs
Storage/Stability
Upon arrival, the protein may be stored for 2 weeks at 4 °C. For long term storage, it is recommended to store at -20 °C or -80 °C in appropriate aliquots. Avoid repeated freeze-thaw cycles.
Write Your Own Review
Your Rating
Submit a review for this product on Biocompare.com to earn an entry into a monthly raffle for one of five $100 Amazon gift cards!

Ask a Question

Display name:
Your location:*
This field is for validation purposes and should be left unchanged.